
Emerging research showed the combination of contrast-enhanced ultrasound (CEUS) with perfluorobutane and modified 2017 LI-RADS criteria had comparable sensitivity, specificity, and accuracy to current magnetic resonance imaging (MRI) and computed tomography (CT) approaches to detecting hepatocellular carcinoma (HCC) lesions.

















































